Sciety network invests in Predicare, the company that aims to streamline emergency care around the world
The Sciety investment syndicate recently completed an investment of MSEK 9 in Predicare, a company that has developed RETTS––a system used by the majority of Sweden’s emergency units. The new capital will be used to expand in selected European markets and further develop the company’s product portfolio.
Gothenburg-based Predicare was founded by an emergency unit doctor and nurse at Sahlgrenska University Hospital who identified the need of a more structured means of assessing care requirements in patients visiting emergency and accident wards. Today, their system RETTS is digitised and is a part of the daily operations of emergency units and ambulances in Sweden.
The system is also used by a major portion of Norway’s emergency units and the company is now facing a broader expansion in Europe. The newly completed financing is a stage in strengthening the company for this expansion and in further developing its product portfolio.
“We are very satisfied with the cooperation with Sciety. They have managed the process in a very good manner and have provided Predicare with access to capital for our continued growth,” states Mathias Myrén, CEO of Predicare.
The company has already received inquiries from potential clients in Europe and Asia.
“We already have discussions with a major healthcare provider in China who has shown interest in the RETTS system. Recently, we were also contacted by a healthcare provider operating hospitals and ambulances services in Austria. In parallel, Predicare is in dialogue with strategically important hospitals in Europe,” notes Mathias Myrén.
Predicare differs from many other innovative technological companies in that it has grown and achieved profitability in Sweden without raising external capital. It is only now, when Predicare will focus more on international expansion, they have chosen to raise capital in order to grow faster.
“Sciety has followed Predicare’s progress during a number of years and chose to invest as the company has a clinically proven product, scalable business model and operates in a growing global market,” states Andreas Lindblom, CEO of Sciety.
More about Sciety
Sciety är ett investeringsnätverk med fokus på svenska tillväxtbolag inom life science. Vill du få nyheter om aktuella bolag och inbjudningar till presentationer med bolagens ledning – anmäl dig här.